Learn everything you need to know about Pemetrexed-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Pemetrexed is an (antifolate) antineoplastic agent, prescribed for mesothelioma (cancer that develops from the protective lining of the internal tissues) and certain types of non-small cell lung ...

"The claim that pemetrexed is superior in adenocarcinoma is one that is not supported by the US FDA [US Food and Drug Administration] and is not supported by a careful consideration of the evidence," ...

Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had pemetrexed and cisplatin. This guidance is a ...

Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: More Questions Than Answers Ramalingam et al 1 reported the results of a phase III trial, ECOG-ACRIN 5508, which compared ...

The Committee considered the evidence on the clinical effectiveness of pemetrexed for the treatment of NSCLC. It considered the data presented by the manufacturer that compared pemetrexed with ...

Pemetrexed and carboplatin is the name of a chemotherapy combination. It includes the drugs we list below, next to each drug we have how you pronounce the drug name in brackets. You have pemetrexed ...

In February 2004, pemetrexed disodium (Alimta; Eli Lilly), an anticancer drug that targets folate-dependent reactions that are essential for cell proliferation, became the first drug to be approved by ...

Pemetrexed and cisplatin is the name of a chemotherapy drug combination. It includes the drugs we list below, next to each drug we have how you pronounce the drug name in brackets. pemetrexed (peh-meh ...

First-line therapy for advanced non–small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ...